Benchmark Starts Tornier (TRNX) at Speculative Buy; Global Player with a Diversified Product Mix
Tweet
Share
E-mailGet Alerts TRNX Hot Sheet
Price: $0.00 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Benchmark initiates coverage on Tornier (NASDAQ: TRNX) with a Speculative Buy. PT $31.00.
Analyst, James Terwilliger, said, "We believe that TRNX is a market leader in the fast growing extremity market. We believe that TRNX has the number two position worldwide for sales of shoulder joint replacement products as measured by revenue. In addition, we believe that TRNX held the number one market position by revenue in the United States in foot and ankle joint replacement systems."
Terwilliger also sees TRNX as a defensive play considering the 'aging of the population' to drive future growth.
For an analyst ratings summary and ratings history on Tornier click here. For more ratings news on Tornier click here.
Shares of Tornier closed at $24.17 yesterday.
Analyst, James Terwilliger, said, "We believe that TRNX is a market leader in the fast growing extremity market. We believe that TRNX has the number two position worldwide for sales of shoulder joint replacement products as measured by revenue. In addition, we believe that TRNX held the number one market position by revenue in the United States in foot and ankle joint replacement systems."
Terwilliger also sees TRNX as a defensive play considering the 'aging of the population' to drive future growth.
For an analyst ratings summary and ratings history on Tornier click here. For more ratings news on Tornier click here.
Shares of Tornier closed at $24.17 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Oppenheimer Starts Carriage Services (CSV) at Outperform
- UBS Starts Schrodinger (SDGR) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
